ryanodine and Thymoma

Myasthenia gravis (MG) patients with thymoma often have antibodies against the calcium-release channel of the sarcoplasmic reticulum (SR) in striated muscle, the ryanodine receptor (RyR). RyR function can be tested in vitro by measuring the degree of [3H]-ryanodine binding to SR. In this study, sera from 9 out of 14 MG patients containing RyR antibodies inhibited [3H]-ryanodine binding to SR membranes from rat skeletal muscle. The 9 patients with antibodies inhibiting ryanodine binding had more severe MG than those with noninhibiting antibodies (P = 0.006). Sera from MG patients with acetylcholine receptor and titin muscle antibodies but no antibodies against RyR and blood-donor sera did not have an inhibiting effect in the [3H]-ryanodine binding assay. The results show that RyR antibodies in MG patients have high affinity for the RyR, and that the binding of antibodies probably affects calcium release from SR by locking the RyR ion channel in a closed position.

Topics: Animals; Autoantibodies; Blood Donors; Connectin; Female; Humans; Male; Muscle Proteins; Muscle, Skeletal; Myasthenia Gravis; Protein Kinases; Radioligand Assay; Rats; Receptors, Cholinergic; Reference Values; Ryanodine; Ryanodine Receptor Calcium Release Channel; Sarcoplasmic Reticulum; Thymoma; Thymus Neoplasms; Tritium

Topics: Autoantibodies; Binding, Competitive; Calcium Channel Blockers; Humans; Muscle, Skeletal; Myasthenia Gravis; Ryanodine; Ryanodine Receptor Calcium Release Channel; Sarcoplasmic Reticulum; Thymoma; Thymus Neoplasms